IBDEI052 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1845,1,4,0)
 ;;=4^E08.610
 ;;^UTILITY(U,$J,358.3,1845,2)
 ;;=^5002531
 ;;^UTILITY(U,$J,358.3,1846,0)
 ;;=E09.40^^3^56^43
 ;;^UTILITY(U,$J,358.3,1846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1846,1,3,0)
 ;;=3^Drug/chem diabetes w neuro comp w diabetic neuropathy, unsp
 ;;^UTILITY(U,$J,358.3,1846,1,4,0)
 ;;=4^E09.40
 ;;^UTILITY(U,$J,358.3,1846,2)
 ;;=^5002564
 ;;^UTILITY(U,$J,358.3,1847,0)
 ;;=E09.41^^3^56^44
 ;;^UTILITY(U,$J,358.3,1847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1847,1,3,0)
 ;;=3^Drug/chem diabetes w neuro comp w diabetic mononeuropathy
 ;;^UTILITY(U,$J,358.3,1847,1,4,0)
 ;;=4^E09.41
 ;;^UTILITY(U,$J,358.3,1847,2)
 ;;=^5002565
 ;;^UTILITY(U,$J,358.3,1848,0)
 ;;=E09.42^^3^56^46
 ;;^UTILITY(U,$J,358.3,1848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1848,1,3,0)
 ;;=3^Drug/chem diabetes w neurological comp w diabetic polyneurop
 ;;^UTILITY(U,$J,358.3,1848,1,4,0)
 ;;=4^E09.42
 ;;^UTILITY(U,$J,358.3,1848,2)
 ;;=^5002566
 ;;^UTILITY(U,$J,358.3,1849,0)
 ;;=E09.43^^3^56^42
 ;;^UTILITY(U,$J,358.3,1849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1849,1,3,0)
 ;;=3^Drug/chem diabetes w neuro comp w diab autonm (poly)neuropathy
 ;;^UTILITY(U,$J,358.3,1849,1,4,0)
 ;;=4^E09.43
 ;;^UTILITY(U,$J,358.3,1849,2)
 ;;=^5002567
 ;;^UTILITY(U,$J,358.3,1850,0)
 ;;=E09.44^^3^56^47
 ;;^UTILITY(U,$J,358.3,1850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1850,1,3,0)
 ;;=3^Drug/chem diabetes w neurological comp w diabetic amyotrophy
 ;;^UTILITY(U,$J,358.3,1850,1,4,0)
 ;;=4^E09.44
 ;;^UTILITY(U,$J,358.3,1850,2)
 ;;=^5002568
 ;;^UTILITY(U,$J,358.3,1851,0)
 ;;=E09.49^^3^56^45
 ;;^UTILITY(U,$J,358.3,1851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1851,1,3,0)
 ;;=3^Drug/chem diabetes w neuro comp w oth diabetic neuro comp
 ;;^UTILITY(U,$J,358.3,1851,1,4,0)
 ;;=4^E09.49
 ;;^UTILITY(U,$J,358.3,1851,2)
 ;;=^5002569
 ;;^UTILITY(U,$J,358.3,1852,0)
 ;;=E09.610^^3^56^35
 ;;^UTILITY(U,$J,358.3,1852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1852,1,3,0)
 ;;=3^Drug/chem diabetes w diabetic neuropathic arthropathy
 ;;^UTILITY(U,$J,358.3,1852,1,4,0)
 ;;=4^E09.610
 ;;^UTILITY(U,$J,358.3,1852,2)
 ;;=^5002573
 ;;^UTILITY(U,$J,358.3,1853,0)
 ;;=E08.51^^3^56^18
 ;;^UTILITY(U,$J,358.3,1853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1853,1,3,0)
 ;;=3^Diabetes due to underlying condition w diab prph angiopath w/o gangrene
 ;;^UTILITY(U,$J,358.3,1853,1,4,0)
 ;;=4^E08.51
 ;;^UTILITY(U,$J,358.3,1853,2)
 ;;=^5002528
 ;;^UTILITY(U,$J,358.3,1854,0)
 ;;=E08.59^^3^56^19
 ;;^UTILITY(U,$J,358.3,1854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1854,1,3,0)
 ;;=3^Diabetes due to underlying condition w oth circulatory comp
 ;;^UTILITY(U,$J,358.3,1854,1,4,0)
 ;;=4^E08.59
 ;;^UTILITY(U,$J,358.3,1854,2)
 ;;=^5002530
 ;;^UTILITY(U,$J,358.3,1855,0)
 ;;=E09.51^^3^56^36
 ;;^UTILITY(U,$J,358.3,1855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1855,1,3,0)
 ;;=3^Drug/chem diabetes w diabetic prph angiopath w/o gangrene
 ;;^UTILITY(U,$J,358.3,1855,1,4,0)
 ;;=4^E09.51
 ;;^UTILITY(U,$J,358.3,1855,2)
 ;;=^5002570
 ;;^UTILITY(U,$J,358.3,1856,0)
 ;;=E09.59^^3^56^48
 ;;^UTILITY(U,$J,358.3,1856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1856,1,3,0)
 ;;=3^Drug/chem diabetes w oth circulatory complications
 ;;^UTILITY(U,$J,358.3,1856,1,4,0)
 ;;=4^E09.59
 ;;^UTILITY(U,$J,358.3,1856,2)
 ;;=^5002572
 ;;^UTILITY(U,$J,358.3,1857,0)
 ;;=E08.618^^3^56^20
 ;;^UTILITY(U,$J,358.3,1857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1857,1,3,0)
 ;;=3^Diabetes due to underlying condition w oth diabetic arthrop
 ;;^UTILITY(U,$J,358.3,1857,1,4,0)
 ;;=4^E08.618
 ;;
 ;;$END ROU IBDEI052
